Allocation of the purchase price

25 October 2019 - Actualité Sorgem Évaluation

Sorgem Evaluation advised Dedalus (Medasys) on the valuation of certain intangible assets as part of its work on purchase price allocation following the acquisition of Infologic Santé.

Sorgem Evaluation acted as a financial adviser to Dedalus (Medasys) on the valuation of intangible assets in connection with the purchase price allocation following the acquisition of Infologic Santé.

Article précédent Article suivant

Actualités

Proposed public buy-out offer by the SMABTP Group – Appointment of Sorgem Evaluation

Proposed public withdrawal offer by the SMABTP Group for Société de la Tour Eiffel at a price of 8.20 euros

2 April 2026

Lire

Actualités

Unfair competition: Judgment of the Paris Court of Appeal in the dispute between Tediber and Emma

In its judgement of 2 April 2025 (Case No. RG 23/05696), the Paris Court of Appeal held that EMMA was

10 April 2025

Lire

Actualités

Sorgem Evaluation was commissioned to model the risk analysis calculations carried out by Euronext

Sorgem Evaluation recently assisted a client who, as part of its derivatives business, needed to switch to the Euronext clearing

10 March 2025

Lire

Ces articles pourraient vous intéresser

Proposed public buy-out offer by the SMABTP Group – Appointment of Sorgem Evaluation

Unfair competition: Judgment of the Paris Court of Appeal in the dispute between Tediber and Emma

Sorgem Evaluation was commissioned to model the risk analysis calculations carried out by Euronext

Have a question or a need?